サマリー

ウベニメクス（別名：ベスタチン）は、競合プロテアーゼ阻害剤です。アミノペプチダーゼB、ロイコトリエンA4ヒドロラーゼ、アミノペプチダーゼNの阻害剤であり、急性骨髄性白血病の治療薬として研究されている。

市場分析とインサイト世界および米国のUbenimex市場
当レポートでは、世界および米国のUbenimex市場に焦点を当てています。
2020年のUbenimexの世界市場規模はXX百万米ドルで、2021-2027年の間にXX％の年率で推移し、2027年末にはXX百万米ドルに達すると予想されています。米国では、Ubenimexの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX％のCAGRで成長すると予測されています。

世界のUbenimexの範囲と市場規模
Ubenimex市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のUbenimex市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、地域（国）別、タイプ別、アプリケーション別に、2016年から2027年までの収益と予測に焦点を当てています。
米国市場では、2016-2027年のUbenimexの市場規模を、プレイヤー別、タイプ別、アプリケーション別に取り上げています。主要なプレイヤーには、アメリカ合衆国で重要な役割を果たす世界的なプレイヤーと地元のプレイヤーが含まれます。

タイプ別セグメント
錠剤
カプセル

用途別セグメント
癌
浮腫
高血圧
その他

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE

会社別
日本化薬
Eiger BioPharma
上海正弦医薬研究所（上海医薬ホールディング）
シノファーム
西安万龍製薬
四川如意製薬
成都Yuandong Biopharmaceutical
浙江省普洛観柳薬業

ページTOPに戻る

目次

1 Study Coverage
1.1 Ubenimex Product Introduction
1.2 Market by Type
1.2.1 Global Ubenimex Market Size Growth Rate by Type
1.2.2 Tablets
1.2.3 Capsule
1.3 Market by Application
1.3.1 Global Ubenimex Market Size Growth Rate by Application
1.3.2 Cancer
1.3.3 Edema
1.3.4 High Blood Pressure
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Ubenimex Market Size, Estimates and Forecasts
2.1.1 Global Ubenimex Revenue 2016-2027
2.1.2 Global Ubenimex Sales 2016-2027
2.2 Global Ubenimex, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Ubenimex Historical Market Size by Region (2016-2021)
2.3.1 Global Ubenimex Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Ubenimex Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Ubenimex Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Ubenimex Sales Forecast by Region (2022-2027)
2.4.2 Global Ubenimex Revenue Forecast by Region (2022-2027)

3 Global Ubenimex Competitor Landscape by Players
3.1 Global Top Ubenimex Manufacturers by Sales
3.1.1 Global Ubenimex Sales by Manufacturer (2016-2021)
3.1.2 Global Ubenimex Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Ubenimex Manufacturers by Revenue
3.2.1 Key Ubenimex Manufacturers Covered: Ranking by Revenue
3.2.2 Global Ubenimex Revenue by Manufacturers (2016-2021)
3.2.3 Global Ubenimex Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Ubenimex Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Ubenimex Revenue in 2020
3.2.6 Global Ubenimex Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Ubenimex Price by Manufacturers
3.4 Global Ubenimex Manufacturing Base Distribution, Product Types
3.4.1 Ubenimex Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ubenimex Product Type
3.4.3 Date of International Manufacturers Enter into Ubenimex Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Ubenimex Market Size by Type (2016-2021)
4.1.1 Global Ubenimex Sales by Type (2016-2021)
4.1.2 Global Ubenimex Revenue by Type (2016-2021)
4.1.3 Ubenimex Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Ubenimex Market Size Forecast by Type (2022-2027)
4.2.1 Global Ubenimex Sales Forecast by Type (2022-2027)
4.2.2 Global Ubenimex Revenue Forecast by Type (2022-2027)
4.2.3 Ubenimex Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Ubenimex Market Size by Application (2016-2021)
5.1.1 Global Ubenimex Sales by Application (2016-2021)
5.1.2 Global Ubenimex Revenue by Application (2016-2021)
5.1.3 Ubenimex Price by Application (2016-2021)
5.2 Ubenimex Market Size Forecast by Application (2022-2027)
5.2.1 Global Ubenimex Sales Forecast by Application (2022-2027)
5.2.2 Global Ubenimex Revenue Forecast by Application (2022-2027)
5.2.3 Global Ubenimex Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
6.1 United States Ubenimex Market Size YoY Growth 2016-2027
6.1.1 United States Ubenimex Sales YoY Growth 2016-2027
6.1.2 United States Ubenimex Revenue YoY Growth 2016-2027
6.1.3 United States Ubenimex Market Share in Global Market 2016-2027
6.2 United States Ubenimex Market Size by Players (International and Local Players)
6.2.1 United States Top Ubenimex Players by Sales (2016-2021)
6.2.2 United States Top Ubenimex Players by Revenue (2016-2021)
6.3 United States Ubenimex Historic Market Review by Type (2016-2021)
6.3.1 United States Ubenimex Sales Market Share by Type (2016-2021)
6.3.2 United States Ubenimex Revenue Market Share by Type (2016-2021)
6.3.3 United States Ubenimex Price by Type (2016-2021)
6.4 United States Ubenimex Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Ubenimex Sales Forecast by Type (2022-2027)
6.4.2 United States Ubenimex Revenue Forecast by Type (2022-2027)
6.4.3 United States Ubenimex Price Forecast by Type (2022-2027)
6.5 United States Ubenimex Historic Market Review by Application (2016-2021)
6.5.1 United States Ubenimex Sales Market Share by Application (2016-2021)
6.5.2 United States Ubenimex Revenue Market Share by Application (2016-2021)
6.5.3 United States Ubenimex Price by Application (2016-2021)
6.6 United States Ubenimex Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Ubenimex Sales Forecast by Application (2022-2027)
6.6.2 United States Ubenimex Revenue Forecast by Application (2022-2027)
6.6.3 United States Ubenimex Price Forecast by Application (2022-2027)

7 North America
7.1 North America Ubenimex Market Size YoY Growth 2016-2027
7.2 North America Ubenimex Market Facts & Figures by Country
7.2.1 North America Ubenimex Sales by Country (2016-2021)
7.2.2 North America Ubenimex Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Ubenimex Market Size YoY Growth 2016-2027
8.2 Asia Pacific Ubenimex Market Facts & Figures by Region
8.2.1 Asia Pacific Ubenimex Sales by Region (2016-2021)
8.2.2 Asia Pacific Ubenimex Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Ubenimex Market Size YoY Growth 2016-2027
9.2 Europe Ubenimex Market Facts & Figures by Country
9.2.1 Europe Ubenimex Sales by Country (2016-2021)
9.2.2 Europe Ubenimex Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Ubenimex Market Size YoY Growth 2016-2027
10.2 Latin America Ubenimex Market Facts & Figures by Country
10.2.1 Latin America Ubenimex Sales by Country (2016-2021)
10.2.2 Latin America Ubenimex Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Ubenimex Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Ubenimex Market Facts & Figures by Country
11.2.1 Middle East and Africa Ubenimex Sales by Country (2016-2021)
11.2.2 Middle East and Africa Ubenimex Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Nippon Kayaku
12.1.1 Nippon Kayaku Corporation Information
12.1.2 Nippon Kayaku Description and Business Overview
12.1.3 Nippon Kayaku Ubenimex Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Nippon Kayaku Ubenimex Products Offered
12.1.5 Nippon Kayaku Recent Development
12.2 Eiger BioPharma
12.2.1 Eiger BioPharma Corporation Information
12.2.2 Eiger BioPharma Description and Business Overview
12.2.3 Eiger BioPharma Ubenimex Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eiger BioPharma Ubenimex Products Offered
12.2.5 Eiger BioPharma Recent Development
12.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
12.3.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporation Information
12.3.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Description and Business Overview
12.3.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ubenimex Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ubenimex Products Offered
12.3.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
12.4 Sinopharm
12.4.1 Sinopharm Corporation Information
12.4.2 Sinopharm Description and Business Overview
12.4.3 Sinopharm Ubenimex Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sinopharm Ubenimex Products Offered
12.4.5 Sinopharm Recent Development
12.5 Xi'an Wanlong Pharmaceutical
12.5.1 Xi'an Wanlong Pharmaceutical Corporation Information
12.5.2 Xi'an Wanlong Pharmaceutical Description and Business Overview
12.5.3 Xi'an Wanlong Pharmaceutical Ubenimex Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Xi'an Wanlong Pharmaceutical Ubenimex Products Offered
12.5.5 Xi'an Wanlong Pharmaceutical Recent Development
12.6 Sichuan Luye Pharmaceutical
12.6.1 Sichuan Luye Pharmaceutical Corporation Information
12.6.2 Sichuan Luye Pharmaceutical Description and Business Overview
12.6.3 Sichuan Luye Pharmaceutical Ubenimex Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sichuan Luye Pharmaceutical Ubenimex Products Offered
12.6.5 Sichuan Luye Pharmaceutical Recent Development
12.7 Chengdu Yuandong Biopharmaceutical
12.7.1 Chengdu Yuandong Biopharmaceutical Corporation Information
12.7.2 Chengdu Yuandong Biopharmaceutical Description and Business Overview
12.7.3 Chengdu Yuandong Biopharmaceutical Ubenimex Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Chengdu Yuandong Biopharmaceutical Ubenimex Products Offered
12.7.5 Chengdu Yuandong Biopharmaceutical Recent Development
12.8 Zhejiang Puluo Kangyu Pharmaceutical
12.8.1 Zhejiang Puluo Kangyu Pharmaceutical Corporation Information
12.8.2 Zhejiang Puluo Kangyu Pharmaceutical Description and Business Overview
12.8.3 Zhejiang Puluo Kangyu Pharmaceutical Ubenimex Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Zhejiang Puluo Kangyu Pharmaceutical Ubenimex Products Offered
12.8.5 Zhejiang Puluo Kangyu Pharmaceutical Recent Development
12.11 Nippon Kayaku
12.11.1 Nippon Kayaku Corporation Information
12.11.2 Nippon Kayaku Description and Business Overview
12.11.3 Nippon Kayaku Ubenimex Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Nippon Kayaku Ubenimex Products Offered
12.11.5 Nippon Kayaku Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Ubenimex Industry Trends
13.2 Ubenimex Market Drivers
13.3 Ubenimex Market Challenges
13.4 Ubenimex Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ubenimex Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer